PPARG and type 2 diabetes mellitus: A comprehensive pharmacologic investigation suggested that fisetin tetramethyl ether could be responsible for T2DM management through T2DM associated signaling pathways and target receptors including proliferator-activated receptor gamma (PPARG)32.